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Abstract 
Cationic liposomes (CLs) are novel non-viral vectors widely used for delivering drugs or 
genes. However, applications of CLs are largely hampered by their cytotoxicity, partly because the 
potential mechanism underlying the cytotoxicity of CLs remains unclear. The aim of the present 
study was to explore the underlying mechanism of cytotoxicity induced by CLs on HepG2 cells. 
Differential metabolites were identified and quantified using ultra-liquid chromatography 
quadrupole time-of-flight mass spectrometry (UHPLC-Q-TOF/MS). The toxicity of CLs on HepG2 
cells was evaluated by multivariate data analysis and statistics. Additionally, CCK-8 assay, 
heatmap, pathway and co-expression network were carried out to explore the relations between 
the metabolites and the pathways. The results showed a dose-dependent toxic effect of CLs on 
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HepG2 cells, with an IC50 value of 119.9 μg/ml. Multivariate statistical analysis identified 42 
potential metabolites between CLs-exposure and control groups. Pathway analysis showed 
significant changes in pathways involving amino acid metabolism, energy metabolism, lipid 
metabolism and oxidative stress in CLs-exposure group vs. control group. Metabolites related to 
the above-mentioned pathways included phenylalanine, methionine, creatine, oxalacetic acid, 
glutathione (GSH), oxidized glutathione (GSSG), choline phosphate and several unsaturated fatty 
acids, indicating that cells were disturbed in amino acid metabolism, energy and lipid supply 
when CLs exposure-induced injury occurred. It is concluded that CLs may induce cytotoxicity by 
enhancing ROS in vitro, affect the normal process of energy metabolism, disturb several vital 
signaling pathways and finally induce cell death. 
Keywords: cationic liposome, UHPLC-Q-TOF/MS, metabolomics, cytotoxicity 
1. Introduction 
Non-viral vectors have been widely used as carriers of drug delivery systems in the 
treatment of cancer (Andresen et al. 2005). Among the non-viral vectors currently available, 
cationic liposomes (CLs) are considered most promising in that they transfer drugs through 
cellular membranes so that they can form electrostatic complexes with plasmid DNA. Various 
cationic lipids have been synthesized and tested for use in non-viral gene delivery (Filion and 
Phillips 1997). Although the transferring efficacy of CLs is substantially lower than that of viral 
vectors, CLs have some unique advantages including biodegradability, design flexibility and cell 
targeting capability (Gujrati et al. 2014; Cortesi et al. 2015). On the other hand, CLs also have 
some unneglectable disadvantages, including high cytotoxicity and other adverse effects (Kagan 
et al. 2005), which greatly hamper wider applications of CLs. Meanwhile, the potential 
mechanism underlying cytotoxicity of CLs has not been well defined.  
There are wide variations in toxicity of non-gene-carrying CLs from different human cells. 
The capacity for nonspecific toxicity due to CLs themselves should be carefully considered when 
drug-containing liposomes are to be administered in humans (Romoren et al. 2004). On the one 
hand, the presence of high concentrations of negative charged plasma proteins may affect the 
surface charge of CLs, or even aggregate CLs into micelles, causing significant cellular toxicity in 
the circulation process (Filion and Phillips 1997). At the same time, some studies in the literature 
pointed out that the activity of cell membranes may disturb the integrity and the membrane 
function of cells or subcellular compartments, causing toxicity (Knudsen et al. 2015). Generally, 
CLs are mainly composed of natural phospholipids containing unsaturated fatty acids, which are 
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easily oxidized, thus reducing the liquidity. Aggregation of CLs in cells prevents them from further 
going through biodegradation and excretion, resulting in unwanted cytotoxicity. Several different 
mechanisms, including oxidative stress, autophagy and certain physicochemical properties of 
nanoparticles (NPs), are reported to be associated with cellular toxicity (Wei et al. 2015; Xie and 
Wu 2016). Many experiments have found that CLs also have toxicity on cells or animals, which 
hinders the clinical application of CLs (Filion and Phillips 1997; Yang et al. 2016). Therefore, 
in-depth study of CLs is needed to explore the toxicity pathways and potential mechanisms 
underlying the vital role of CLs for the sake of widening the clinical application of CLs. 
Metabolomics has emerged as a new discipline to study issues closely related to human 
health (Lindon et al. 2003). Meanwhile, the research on analysis of disease states as well as in 
basic research to study biological processes or in predictive toxicology has gradually attracted 
wide attention. Metabolomics is concerned with the analysis of all small endogenous metabolites 
in order to investigate the relationship between metabolites and toxic stimulating factors 
(Robertson 2005). It become a forceful tool for prospecting new high value compounds, taking 
insight into the potential toxicity mechanisms, and might have remarkable assistance for 
preventing the cellular toxicity in clinical (Tan et al. 2017). The liver is the main organ of metabolic 
clearance and has been recognized as the target site for drugs and nanoparticles (NPs). Evidence 
has shown that NPs preferentially deposit in the liver under systemic exposure, resulting in 
prolonged retention within the organ (B. Wang et al. 2013). Knowing that HepG2 is a hepatocyte 
carcinoma derived cell line and thought to be a more realistic and relevant model of hepatocyte 
behavior, we chose HepG2 to carry out our investigation (Johnston et al. 2010). Additionally, an 
UHPLC-Q-TOF/MS based metabolomics approach was carried out to analyze the potential 
mechanism underlying cellular toxicity of CLs exposure on HepG2 cells (G. Wang et al. 2016). 
The aim of the present study was to evaluate the cellular toxicity of CLs on HepG2 cells, 
screen metabolites that undergo significant changes, and discuss the potential toxicity 
mechanism of CLs. Based on the screened metabolites, we used the free online MetaboAnalyst 
software to analyze the obtained statistical data and further create a heatmap via multivariate 
statistical analysis, cluster grams, and pathway analysis. The results demonstrate that 
metabolomics is a powerful method to gain insight into the toxicity mechanisms. To the best of 
our knowledge, the data shed lights on the mechanisms underlying the cellular toxicity of CLs and 
might have important implications for developing safe gene delivery systems. 
2. Materials and Methods 
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2.1 Chemicals and equipment 
Chemicals and equipment used in this study were optima grade methanol, formic acid, 
chloroform and acetonitrile of chromatographic grade (Merck); 1, 
2-dioleoyl-3-trimethylammonium-propane (DOTAP) (890890P), cholesterol and DSPE-PEG 2000 
(Avanti Polar Lipids, AL, USA); 3-Chloro-L-phenylalanine (Aladdin Reagent Co., Ltd); fetal bovine 
serum (FBS), penicillin, streptomycin phosphate-buffered saline (PBS) and DMEM (Invitrogen, CA, 
USA); deionized water purified by Millipore purification system (Millipore, MA, USA); and Cell 
Counting Kit (CCK-8) (Dojindo Laboratories, Kumamoto, Japan). All the other chemicals used in 
our research were of the highest analytic grade. 
2.2 Preparation and characterization of CLs 
CLs were synthesized by using the classical film dispersion method as described before (Yu et 
al. 2016; Kono et al. 2016). Briefly, DOTAP, cholesterol and DSPE-PEG 2000 at a molar ratio of 
11:8:1 were dissolved in chloroform solution and mixed in a round-bottomed flask for about 1 h. 
Then the organic solvents were removed from the lipid solution with a rotary evaporator. 
Subsequently, the lipid film was hydrated with 10 ml PBS to create the multilamellar liposomes. 
Then the nano-scale unilamellar vesicles were prepared by forcing out the multilamellar 
liposomes using a liposomes extruder LF-1 (Avestin, Inc, Canada) at 56 °C. Extrusion was 
accomplished in a step wise manner by performing membranes with progressively decreasing 
pore sizes (400, 200, 100 nm, Whatman Nuclepore membrane, Fisher Scientific, MA, USA), with 
10 cycles per pore size. CLs were then stored at 4 °C until use. The mean particle size, zeta 
potential and polydispersity index (PDI) of the CLs were measured using a Malvern Zetasizer ZS90 
(Malvern Instruments, Ltd., UK).  
Before measurement, newly prepared CLs were appropriately diluted 1:10 in H2O and all the 
operations were performed at room temperature after equilibration for 10 min. Data were 
expressed as an average of three measurements. 
2.3 Cell culture 
The human hepatocellular carcinoma (HCC) cell line HepG2 was maintained in DMEM 
supplemented with 10% (v/v) FBS, penicillin (100 units/mL) and streptomycin (100 μg/mL). Cells 
were routinely cultured under the standard condition of 37 °C, 5% CO2 and 95% humidity 
(Thermo Scientific, SERIESⅡ WATER JACKET). 
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2.4 CCK-8 assay 
Cellular toxicity of CLs was assessed in HepG2 cells using the CCK-8 assay as described 
previously (Ko et al. 2015). During the experiment, HepG2 cells were seeded into a 96-well plate 
at a density of 1×104 cells per well and cultivated for 24 h to facilitate attachment to the surface, 
and then exposed to 100 μl culture medium with a concentration range of CLs for another 24 h; 
untreated cells were used as control groups and each group was further divided into 4 parallel 
wells. After treatment with CCK-8 solution for another 4 h at 37 °C, the absorbance was 
measured at 450 nm using an absorbance microplate reader (Thermo Fisher Scientific Inc., 
Multiskan, MK3). Subsequently, cell viability was compared with that of the control using the 
following equation: Aa/Ab×100, where Aa and Ab are the absorbance of experimental samples and 
controls, respectively. Half-maximum inhibitory concentration (IC50) values of CLs were calculated 
by the Graphpad software. 
2.5 Sample collection and preparation 
Cells were cultured overnight in a 100-mm dish at a density of 1×106 cells per dish, followed 
by incubation with a concentration of IC50 of CLs for 24 h. In each experiment, untreated cells 
were used as control and six biological replicates were performed. Next, cell lysates were 
obtained by adding 1 ml of cold methanol to each dish and mechanically harvested with a sterile 
plastic disposable cell scraper. Each dish was washed with an additional 500 μl cold methanol 
that was collected into the respective Eppendorf® tube. Recovered cell lysate was vortexed for 1 
min and further centrifuged at 13,000×g for 15 min at 4 °C. The supernatant was collected and 
stored in a new 1.5 ml Eppendorf® tube at -80 °C. The methanol solution was evaporated to 
dryness and the sample was re-suspended in 250 μl pre-cooling reagent (methanol: chloroform, 
9:1) containing 1 µg/ml 3-chloro-L-phenylalanine as the internal standard. After being vortexed 
for 2 min, the sample was centrifuged at 13,000×g, 4 °C for 15 min, and then added with 200 µl 
supernatant in the sample vial for LC-MS analysis. A QC sample was accomplished by mixing 
aliquots from each supernatant (10 µl per sample). 
2.6 Chromatography and mass spectrometry conditions 
An Agilent Infinity 1290 series instrument (Agilent, CA, USA) equipped with an auto sampler 
delivery system was used for UHPLC analysis. The chromatographic separation was performed on 
a HSS T3 column (100 mm × 2.1 mm, 2.5 µm, Waters Corporation, USA). The mobile phase 
consisted of 0.05% formic acid (solvent A) and acetonitrile with 0.05% formic acid (solvent B). The 
column temperature was maintained at 25 °C and the injection volume was 3 μl. Post time was 
This article is protected by copyright. All rights reserved.
  
set at 5 min and the flow-rate was 0.40 ml/min. The optimized elution condition was applied as 
follows: 0-2 min, 5% B; 2-17 min, 5-95% B; 17-19 min, 95% B. 
The UHPLC system was connected to an Agilent 6538 accurate mass quadrupole 
time-of-flight mass spectrometer (Agilent Technologies, USA) with an electrospray ionization 
source operating in both positive and negative modes. The ESI source conditions were optimized 
as follows: capillary voltage, 4 kV in positive mode and 3.5 kV in negative mode; drying gas flow, 
11 L/min; gas temperature, 350 °C; Nebulizer pressure, 45 psig; fragmentor voltage, 120 V; 
skimmer voltage, 60 V; collision energy, 10, 20, 30, and 40 eV. Accurate LC-MS mass spectra were 
recorded across an m/z range of 100 to 1200 Da. The MS/MS method was applied to further 
confirm the biomarkers. 
2.7 Data processing and statistical analysis 
UHPLC-Q-TOF/MS spectra of all determined samples were recorded and converted into a 
common data file format (mzdata); subsequently, the collected data were extracted by molecular 
feature extraction with the retention time (Rt), m/z value, and the corresponding intensities for 
all detected peaks in the data set. The 80% rule was used to select the ions, and then 
normalization and auto-scaling of the ion peaks were performed. To compare the differences of 
the two groups and find out the significant metabolites, a Student’s t-test of all the screened 
peaks was carried out using IBM SPSS Statistic Version 17.0 (IBM, New York, USA). The data set 
containing all the peak area corresponding to the concentration of a certain metabolite was 
exported to the SIMCA-P software (version 11, Sweden) for PCA and PLS-DA analysis. PLS-DA 
produced the key parameters: R2X (the cumulative model variation in X), R2Y (the cumulative 
model variation in Y) and Q2 (the cumulative predicted variation). As these parameters 
approached 1.0, a model with predictive reliability appeared. 
All data showed in the figures are expressed as the means ± standard deviation (SD) and 
were assessed using the ANOVA or the Student’s t-test. Differences between the two groups 
were considered statistically significant using the least significant differences at the values of p < 
0.05.  
3. Results 
3.1 Characterization of CLs 
CLs were characterized using a Zetasizer ZS90 to determine their diameter and size 
distribution. All samples were diluted 10-fold with ultrapure water. PDI was a measure of the 
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uniformity of particle sizes present in the suspension, ranging from 0 (mono dispersed) to 1 (very 
broad distribution), knowing that its value can reflect the homogenous size distribution of CLs. 
The physical parameters measured by the Malvern particle size analyzer are shown in Table 1. 
The size and zeta potential distributions are shown in Fig S1. Data are expressed as the mean ± 
standard deviation (SD). All measurements were carried out in triplicate at 25 °C after 3 min 
equilibration. It was found that CLs were well dispersed and uniform in shape and size. 
3.2 Cellular toxicity of CLs 
The potential effect of CLs on toxicity of HepG2 cells was investigated. The results 
demonstrated that the number of HepG2 cells was decreased markedly in a 
concentration-dependent manner after exposure to CLs, with an IC50 value of 119.9 μg/ml (Fig 1).  
In addition, no obvious cellular toxicity was observed when the dose of CLs was lower than 50 
μg/ml. But when the dose of CLs was increased to the highest level for 24 h, the inhibitory effect 
increased by approximately 96%, suggesting that CLs reduced the viability of HepG2 cells 
remarkably. To identify the alternated level of metabolites more exactly and accurately, an IC50 
value of 119.9 μg/ml was chosen for subsequent experiments.  
3.3 Method validation 
The UHPLC-Q-TOF/MS system was used to detect the cell samples. The representative total 
ion current (TICs) chromatograms of both groups gained from positive and negative mode are 
shown in Fig S2. 
A QC sample was applied to validate the system performance and obtain complementary 
product ion information. At the same time, five selected ions were calculated for the relative 
standard deviation (RSD) of the retention time and the peak area for validation. The RSD of 
retention time was less than 1% and the peak area was less than 5%, demonstrating that the 
method was precise, stable and reliable for subsequent analyses. 
3.4 Metabolomics analysis 
To gain the whole metabolic information and investigate the alteration, the pattern 
recognition methods such as PCA and PLS-DA were performed on the resulting complex 
multivariate data set. Major metabolites were identified by high-resolution mass spectrometry 
and MS/MS experiments. The typical score plots between the control and CLs groups are shown 
in Fig 2. PCA was looking forward to searching the intrinsic variation in the data set, and the 
results (Fig 2 A and B) indicate that the clusters of the extracts from CLs group were clearly 
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separated from those of the relevant control, suggesting a significant alteration in the metabolic 
profile induced by CLs. 
Knowing that PLS-DA is a supervised method mainly for discovering variation, it was used to 
identify metabolic differences between the two groups in this study. The pair-wise PLS-DA score 
plots in positive and negative ion modes are shown in Fig 2 C, D and Fig S3, showing a significant 
difference between CLs and corresponding control groups. In the PLS-DA model, S-plots are 
usually used to identify the features contributing to group discrimination. Each spot represents 
an endogenous substance, and the spots located at the ends of the plot will contribute more to 
the differentiation between groups (Fig 2 E and F). 
3.5 Identification of differential metabolites 
UHPLC-MS and metabolomics data analyses were used to assess the difference in the 
metabolic profile within cells exposed to CLs vs. the untreated control. The potential metabolites 
were picked out according to Variable Importance in the Project at the values of VIP >1.0, and the 
S-plot. Some of these metabolites and the interpretation of significant ion peaks were preceded 
by searching metabolic databases including HMDB, KEGG, and METLIN. In addition, these 
candidate metabolites from both groups were verified by comparison of the retention time and 
fragmentation pattern with authentic standards according to the MS/MS experiments. 
Subsequently, the literature and KEGG database (http://www.genome.jp/kegg/) were selected to 
interpret the pathways of the metabolites. Altogether 42 differential metabolites, including 23 in 
positive and 19 in negative modes, were identified, and the details are shown in Table 2. 
3.6 Function analysis and metabolic pathway 
To visualize the level of metabolite change, a heatmap was built according to the peak area 
transformed data of metabolites. The heatmap based on the 42 metabolites showed significant 
differences between CLs and control groups (Fig S4), based on which a metabolic pathway 
analysis was further performed to evaluate their associated pathways. The result showed that the 
changed metabolites identified were primarily involved in amino acid metabolism, energy 
metabolism, lipid and oxidative stress. Fig 4 shows an overview of the pathway analysis, with the 
x-axis (the pathway impact value calculated from pathway topological analysis) and the y-axis 
(corresponding to the -log (p) value obtained from pathway enrichment analysis), with the most 
impacted pathways colored. Consequently, nine most significantly different pathways were 
considered closely related to the potential cellular toxicity induced by CLs. These pathways 
involved arachidonic acid metabolism, D-glutamine and D-glutamate metabolism, sphingolipids 
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metabolism, pantothenate and CoA biosynthesis, GSH metabolism, TCA cycle, phenylalanine 
metabolism, glycerophospholipid metabolism, and purine metabolism. 
Based on the KEGG pathway database, we established the metabolic network (Fig 4), which 
clearly showed that CLs were related to the above-mentioned metabolites. 
4. Discussion 
To further explore cellular toxicity of CLs on HepG2 cells, we investigated the metabolic 
alterations in HepG2 cell extracts after 24-h continuous incubation with CLs by employing the 
UHPLC-Q-TOF/MS-based metabolomics approach. Subsequent analysis of the metabolite profiles 
of the samples from HepG2 cells provided a fingerprint of metabolic changes and highlighted the 
potential of metabolomics analysis in the evaluation of toxicity. About 42 metabolic biomarkers 
were highly possible to be associated with CLs-exposure, because they showed better 
performance in terms of both specificity and sensitivity. These differential metabolites mostly 
included amino acids, lipids, and fatty acids. 
In our study, nine unique metabolic pathways were identified from CLs and control groups 
(Fig 3). The altered metabolites related to CLs-exposure were mainly involved in amino acid 
metabolism, energy metabolism, oxidative stress metabolism and lipid metabolism (Fig 4). 
4.1 Amino acid metabolism 
One recent study (Wei et al. 2015) reported that CLs could impair the activity of 
Na+/K+-ATPase in cells, leading to cell anoxia and acute cell necrosis. Cell necrosis is known to 
affect endogenous metabolites. Amino acids are the most fundamental substances in the 
organism and the most important substrate materials for synthetic proteins closely related to the 
life activities of cells. 
Phenylalanine belonging to aromatic amino acid is a kind of essential amino acid and the 
precursor for tyrosine. On the one hand, phenylalanine is used to synthesize proteins in diverse 
cells; most phenylalanine in vivo is catalyzed by phenylalanine hydroxylase to generate tyrosine. 
In addition, tyrosine is further synthesized into essential hormones to participate in sugar and 
lipid metabolisms. On the other hand, only a small proportion of phenylalanine is metabolized 
into phenylpyruvic acid (Du et al. 2016). Glutamic acids are substances required for the 
production of glutathione (GSH), the most abundant natural antioxidant in the body. It was found 
in our study that the content of GSH was increased, probably due to CLs-induced oxidative stress, 
which in turn increased glutamate and glycine to contribute to GSH production. In addition, a 
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panel of amino acids (phenylalanine, tyrosine, glutamic acid and citrulline) underwent significant 
changes in HepG2 cells compared with those in control group. These changes may be partly 
attributed to the disordered amino acid metabolism. 
4.2 Energy metabolism 
Energy metabolism is the key element in the regulation of life and death. Multiple 
metabolites such as creatine, oxalacetic acid, ATP and NADH are known to pay important roles in 
the cycle of energy metabolism. 
Creatine is part of the cellular energy shuttle synthesized mainly in the liver by making use of 
arginine, glycine, and methionine. It was found in our study that creatine was increased 
significantly in CLs group as compared with that in control group, indicating a perturbation of 
energy metabolism in HepG2 cells exposed to CLs. This finding, together with previous findings, 
may indirectly suggest that disturbed energy metabolism is involved in CLs exposure. Oxalacetic 
acid and thiamin diphosphate are important intermediates in TCA cycle. TCA cycle in association 
with oxidative phosphorylation is the major pathway in cellular energy production. On the other 
hand, phosphocholine is generated in a reaction catalyzed by choline kinase that converts ATP 
and choline into phosphocholine and ADP. Thus, change in phosphocholine implies that there is 
some disturbance in energy metabolism induced by CLs in HepG2 cells. At the same time, choline 
is a major constituent part of the cell membrane and plays an essential role in the integrity of cell 
membranes and lipid metabolism. The elevated concentrations of choline in the extracts denote 
the disruption of membrane fluidity caused by CLs. The production of energy partly depends on 
the oxygen-dependent electron transfer chain in cells; once the process is disturbed, the 
concentration of NADH, FADH2 and ubiquinone-4 is altered in cells. In our study, AMP and ADP 
levels in CLs group were markedly decreased as compared with those in control group, suggesting 
that disturbed energy metabolism may be involved in CLs exposure. Pantothenic acid is the 
precursor of coenzyme A (CoA), and also plays a significant role in lipid metabolism or as a 
prosthetic group in TCA cycle (Li et al. 2010; Monteiro et al. 2015). The increased level of 
pantothenic acid suggests that CLs exposure might induce the disturbance of coenzyme A and 
TCA cycle. 
4.3 Oxidative stress 
GSH is the most abundant amino acid and plays an important role in anti-oxidation. It can 
protect some thiol containing proteins or enzymes from being damaged by oxidants, especially 
peroxide (Hussain et al. 2005). In the current investigation, we found significant alterations in the 
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levels of GSH and GSSG in HepG2 cells, suggesting that CLs exposure could induce free radicals, 
which is consistent with the previous finding that liposome-exposure could promote the 
production of produced reactive oxygen species (ROS) (Jia et al. 2009; Gioria et al. 2016). ROS is a 
key signal to transmit environmental stimuli in cells in response to stress. The surface of the NPs 
could cause oxidative stress, thus increasing intracellular calcium and gene activation, or 
intracellular distribution of NPs may affect mitochondria thereby generating oxidative stress (F. 
Wang et al. 2009). 
Leukotriene (LT) and prostaglandin (PG) are minor metabolites of arachidonic acid under the 
action of inflammatory stimulation. They are also vital inflammatory mediators. It was found in 
our study that LTE4 and PGH2 levels were upregulated in CLs group, suggesting that CLs exposure 
may induce inflammation in HepG2 cells. Our experimental data demonstrate that oxidative 
stress caused by NPs could induce inflammation, resulting in DNA damage, which is consistent 
with the result of another study (Ma et al. 2011; Trinei et al. 2002). Adenine and dUMP are 
nucleotides, and the substrates of DNA or RNA as well (Davies et al. 2012; Rai et al. 2009). In the 
CLs-exposed modes, we observed a significant increase in the content of the above nucleotides, 
indicating that CLs exposure triggered the inflammatory process and disturbed nucleotides. 
4.4 Lipid metabolism 
Numerous studies have demonstrated that disturbance of lipid metabolism plays a pivotal 
role in the progression of toxicity of NPs exposure (Rajiv et al. 2016;Tian et al. 2016;Arisaka et al. 
2011). An earlier transcriptomic study from our group found significant perturbations in mRNA 
associated with lipid metabolism in HepG2 cell extracts after CLs exposure. Both PC and GPC are 
derivatives of choline and two main storage forms of choline in the cytoplasm. Choline-like 
metabolites are involved in several important pathways, playing signaling and structural roles in 
cell membranes and immune response. It was found in this study that the content of these two 
metabolites was both significantly up-regulated in CLs group, indicating that the increase in these 
metabolites may help remove damaged cells after CLs exposure. Three unsaturated fatty acids 
(arachidonic acid, 17-hydroxylinolenic acid and docosahexaenoic acid) were also increased 
markedly in CLs group. Arachidonic acid, which is known to possess inflammatory 
response-mediating properties, is a polyunsaturated essential fatty acid and a vital component of 
phosphatides. However, arachidonic acid has cytotoxicity and may work as a physiological 
mediator of cell death. 17-hydroxylinolenic acid and docosahexaenoic acid are two important 
polyunsaturated fatty acids that play a vital role in many metabolic and cell signaling processes. 
We also observed a significant increase in some metabolites including ceramide and cholesterol 
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in CLs group vs. control group. Therefore, the significant perturbations in these lipid metabolites 
may be closely related to lipid metabolic dysfunction of CLs-induced cell death.  
The process of fatty acid degradation, also known as beta-oxidation, converts an aliphatic 
compound into a set of activated acetyl units (acetyl CoA) that can be processed by TCA cycle. 
Carnitine cycle is the first step for fatty acid oxidation, in which fatty acyl CoA enters the 
mitochondria as fatty acyl carnitines via carnitine transport. Numerous disorders involving energy 
production and excretion of unusual acylcarnitines have been described. In this study, 
acetylcarnitine and palmitoylcarnitine were decreased in CLs group, indicating that the 
abnormality of fatty acid metabolism might be associated with the toxicity of CLs. Bile acids are 
physiological detergents that facilitate the excretion, absorption and transport of fats and sterols. 
The increased concentration of cholic acid in CLs group was observed, suggesting that CLs could 
disturb bile biosynthesis and cholesterol metabolism. 
4.5 Other metabolisms 
Sarcosine, SAM and N5-Formyl-THF are sources of methyl groups. The methylation process 
helps cells respond to stress, detoxify xenobiotics and generate methylated compounds. The lack 
of methyl will affect the methylation of DNA and RNA, thus interfering with nucleic acid synthesis 
and affecting the normal metabolism of overall circulation. The change of methyl, as reflected in 
the concentrations of these metabolites with methyl sources such as choline, sarcosine, SAM, 
and N5-Formyl-THF, suggesting that methylation plays a vital role in detoxification of CLs 
exposure. 
5. Conclusions 
Recent advances in metabolomics technologies have made it possible to analyze a wide 
range of bimolecules qualitatively and quantitatively, and determine their relative abundance in 
different biological conditions. In the present research, UHPLC-Q-TOF/MS-based metabolomics 
method coupled with multivariate data analysis was employed to evaluate the toxicological effect 
of CLs in vitro. A total of 42 differentially expressed metabolites induced by CLs were screened 
between CLs and control groups. These metabolites belonged to the classification of amino acids, 
fatty acids and lipids and were mainly associated with the distribution of some metabolic 
pathways including amino acid metabolism, energy metabolism, and the metabolism of 
phospholipid and fatty acid. Our results highlight that CLs may exert their toxicity via different 
pathways, although this postulation needs to be verified by more studies.  
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Our findings demonstrate that the metabolomics approach can be employed as a tool to 
understand the toxicity mechanism of CLs. In addition, these results may serve as useful clues for 
further investigations needed to better understand the toxicity mechanisms of CLs. Our ongoing 
study will construct a molecular network to further explore the mechanism underlying 
cytotoxicity of CLs by transcriptomics and proteomics analysis.  
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Table 1. The physical characterizations of CLs 
Polymer Size (nm) PDI ZP (mV) 
CLs 152.2±4.04 0.117±0.013 8.38±4.96 
PDI=polydispersity index, ZP=zeta potential, n=3
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Table 2. Significant metabolomics profiles measured by UHPLC-Q-TOF/MS 
No. m/z RT VIP Ion Formula Metabolites Pathways FC(CLs/C) 
1 175.1857 0.9805 1.791 [M-H]- C6H13N3O3 Citrulline Amino acids metabolism 1.373 ↑## 
2 307.323 0.9927 2.731 [M+H]+ C10H17N3O6S GSH Glutathione metabolism 3.461 ↑# 
3 308.1819 0.9977 1.043 [M+H]+ C9H13N2O8P dUMP Energy metabolism 0.514 ↑# 
4 612.631 1.0039 2.577 [M-H]- C20H32N6O12S2 Oxidized glutathione Glutathione metabolism 3.155 ↑# 
5 135.1267 1.1637 1.167 [M+H]+ C5H5N5 Adenine Purine metabolism 0.534 ↑## 
6 131.1332 1.2292 5.225 [M+H]+ C4H9N3O2 Creatine Energy metabolism 11.53 ↑# 
7 132.0716 1.2304 1.446 [M+H]+ C4H4O5 Oxalacetic acid Energy metabolism 0.913 ↑# 
8 164.158 1.7637 1.053 [M+H]+ C9H8O3 Phenylpyruvic acid Amino acids metabolism 0.446 ↑## 
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9 181.1885 1.7645 2.248 [M+H]+ C9H11NO3 L-Tyrosine Amino acids metabolism 2.095 ↑# 
10 352.4651 2.165 1.146 [M-H]- C20H32O5 Prostaglandin H2 Arachidonic acid metabolism 0.615 ↑## 
11 294.429 2.1922 1.049 [M-H]- C18H30O3 17-Hydroxylinolenic acid Lipid metabolism -0.519 ↓## 
12 166.1739 2.2008 1.803 [M+H]+ C9H10O3 Phenyllactate Others 1.297 ↑## 
13 463.2934 2.34073 2.341 [M-H]- C14H18N5O11P Adenylsuccinic acid Purine metabolism 2.481 ↑# 
14 439.609 2.8098 1.609 [M-H]- C23H37NO5S Leukotriene E4 Arachidonic acid metabolism 1.006 ↑### 
15 147.1293 2.8127 1.320 [M-H]- C5H9NO4 D-Glutamic acid Amino acids metabolism 0.706 ↑### 
16 89.0932 2.8134 1.038 [M-H]- C3H7NO2 Sarcosine Others -0.439 ↓### 
17 219.235 2.8583 2.496 [M+H]+ C9H17NO5 Pantothenic acid Others 2.298 ↑## 
18 355.4358 3.0647 3.065 [M-H]- C14H23N6O3S S-Adenosylmethioninamine Others 4.551 ↑# 
19 165.1891 3.652 4.972 [M+H]+ C9H11NO2 L-Phenylalanine Amino acids metabolism 10.05 ↑# 
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20 408.5714 4.0763 1.782 [M-H]- C24H40O5 Cholic acid Others 1.252 ↑### 
21 567.3536 4.65051 4.651 [M-H]- C27H54NO9P Docosahexaenoic acid Lipid metabolism 10.444 ↑# 
22 203.1158 5.329 1.785 [M-H]- C9H17NO4 Acetylcarnitine Lipid metabolism 1.338 ↑# 
23 347.2212 5.4837 1.101 [M+H]+ C10H14N5O7P AMP Energy metabolism -0.606 ↓# 
24 458.3597 6.0405 1.104 [M+H]+ C17H23N4O9P FMNH2 Energy metabolism -0.576 ↓## 
25 473.4393 6.0757 1.220 [M+H]+ C20H23N7O7 N5-Formyl-THF Others -0.713 ↓## 
26 386.6535 8.9855 1.013 [M+H]+ C27H46O Cholesterol Lipid metabolism -0.306 ↓### 
27 299.2149 9.4478 1.322 [M+H]+ C9H18NO8P D-4'-Phosphopantothenate Others 0.578 ↑### 
28 496.3403 10.492 1.035 [M+H]+ C24H51NO7P Palmitoylglycerophosphocholine Lipid metabolism -0.366 ↓## 
29 399.6077 10.582 1.988 [M+H]+ C23H45NO4 L-Palmitoylcarnitine Lipid metabolism 1.367 ↑### 
30 453.5503 10.582 2.403 [M-H]- C21H44NO7P LysoPE(16:0/0:0) Lipid metabolism 2.651 ↑# 
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31 454.6414 10.59 1.178 [M-H]- C29H42O4 Ubiquinone-4 Energy metabolism 0.635 ↑# 
32 481.7944 10.639 1.180 [M-H]- C30H59NO3 Ceramide (d18: 1/12:0) Lipid metabolism 0.579 ↑## 
33 425.314 10.762 1.892 [M+H]+ C12H19N4O7P2S Thiamin diphosphate Energy metabolism 1.246 ↑### 
34 390.2345 11.257 1.247 [M-H]- C11H19O13P 1-Phosphatidyl-D-myo-inositol Lipid metabolism 0.606 ↑### 
35 523.6832 11.333 2.423 [M-H]- C26H54NO7P LysoPC(0:0/18:0) Lipid metabolism 2.549 ↑# 
36 427.2011 11.408 1.052 [M+H]+ C10H15N5O10P2 ADP Energy metabolism -0.351 ↓### 
37 665.441 11.804 1.835 [M+H]+ C21H29N7O14P2 NADH Energy metabolism 1.334 ↑## 
38 779.5218 12.123 1.218 [M+H]+ C40H77NO11S 3-O-Sulfogalactosylceramide Lipid metabolism 0.501 ↑### 
39 735.9686 12.297 2.450 [M+H]+ C38H74NO10P PS (16:0/16:0) Lipid metabolism 1.876 ↑### 
40 465.6273 12.301 1.875 [M-H]- C23H50N2O5P LysoSM (d18:1) Lipid metabolism 1.680 ↑# 
41 648.8913 12.549 1.282 [M+H]+ C35H69O8P PA (16:0/16:0) Lipid metabolism 0.530 ↑### 
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42 304.4669 14.845 2.091 [M-H]- C20H32O2 Arachidonic acid Lipid metabolism 2.007 ↑## 
(↓): means decreased; (↑): means increased. 
#: P < 0.05; ##: P < 0.01; ###: P < 0.001 (compared with control group); 
CLs-cationic liposomes group, C-control group 
Fold change was calculated as the logarithm of the average mass response (area) ratio between the two groups (Fold change=Log2 [CLs/C])
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Fig 1. The inhibition rate of HepG2 cells treated with different concentrations of CLs. 
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Fig 2. PCA scores, PLS-DA scores, S-plot between control and CLs groups in positive and negative 
mode. A: PCA score in positive mode (R2X=0.995, Q2=0.793), B: PCA score in negative mode 
(R2X=0.982, Q2=0.765), C: PLS-DA score in positive mode (R2X=0.855, R2Y= 0.998, Q2Y=0.981), D: 
PLS-DA score in positive mode (R2X=0.926, R2Y= 0.999, Q2Y=0.964), E: S-plot in negative mode, F: 
S-plot in negative mode. 
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Fig 3. Impact on metabolic pathways suggested by the metabolites identified in HepG2 cells. (A) 
Arachidonic acid metabolism, (B) D-glutamine and D-glutamate metabolism, (C) Sphingolipid 
metabolism, (D) Pantothenate and CoA biosynthesis, (E) Glutathione metabolism, (F) TCA cycle, 
(G) Phenylalanine metabolism, (H) Glycerophospholipid metabolism, (I) Purine metabolism 
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Fig 4. The network of metabolic pathways influenced by CLs in HepG2 cells. Identified differential 
metabolites in CLs group compared to the Control group are labeled in red (down-regulated) 
green (up-regulated) and yellow (not detected), respectively. 
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